BioCentury
ARTICLE | Clinical News

GLYX-13: Phase IIa data

December 10, 2012 8:00 AM UTC

A double-blind, U.S. Phase IIa trial in 116 patients with HDRS-17 scores of >=21 units and who failed >=1 antidepressant during the current depressive episode showed that a single 10 mg/kg dose of IV ...